Type:
Educational Exhibit
Keywords:
Oncology, Soft tissues / Skin, CT, Diagnostic procedure, Cancer
Authors:
T. Tan, D. Loh, T. Lo, M. Bressel, M. Chua, V. Estall, M. Johnston, K. Pope; VIC/AU
DOI:
10.1594/ranzcr2016/R-0025
Background
Melanoma is the 3rd overall most common cancer in Australia (excluding non-melanoma skin cancer),
with the second highest incidence of Melanoma of the skin cancer in the world.[1]
Even after curative treatment,
risk of relapse for stage III melanoma is high[2].
Early detection is key in precipitating early intervention for low volume disease,
allowing for improved survival outcomes[3,4].
Despite this,
there is limited published data to guide an overall consensus for follow-up strategies with stage III melanoma,
and guideliens have largely been empirical[5].
We study stage III melanoma between 2001 and 2006 at Peter MacCallum Cancer Centre retrospectively to document patterns of recurrence,
as well as explore potential risk factors for recurrence